Condition
Schizophrenia and Other Psychotic Disorders
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Not Yet Recruiting3
Unknown1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07506070Not ApplicableNot Yet Recruiting
Implementing Action-Based Cognitive Remediation for Transdiagnostic Cognitive Difficulties in a Tertiary Mental Health Hospital
NCT07427810Not Yet Recruiting
Follow-up of Adolescents With Autism and Psychotic Symptoms - Psychiatric Co-morbidity and Functional Impairment.
NCT07237529Not ApplicableNot Yet Recruiting
What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis?
NCT03995121RecruitingPrimary
SV2 PET Imaging With [11C]APP311
NCT04700930Not ApplicableUnknownPrimary
CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia
Showing all 5 trials